(Q40673293)

22 September 2017

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication (English)

1 reference

eradication of infectious diseases

22 September 2017

1 reference

1

Roger J Pomerantz

1 reference

PubMed ID

11731950

22 September 2017

language of work or name

English

0 references

publication date

21 November 2001

1 reference

Clinical Infectious Diseases

22 September 2017

1 reference

22 September 2017

34

1 reference

22 September 2017

1

1 reference

22 September 2017

91-97

1 reference

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

22 September 2017

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

21 January 2018

1 reference

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

21 January 2018

1 reference

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

21 January 2018

1 reference

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

21 January 2018

1 reference

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

21 January 2018

1 reference

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

21 January 2018

1 reference

Generation of HIV latency during thymopoiesis

21 January 2018

1 reference

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

21 January 2018

1 reference

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

21 January 2018

1 reference

Infection of the retina by human immunodeficiency virus type I.

21 January 2018

1 reference

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

21 January 2018

1 reference

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years

21 January 2018

1 reference

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

21 January 2018

1 reference

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

21 January 2018

1 reference

Poor penetration of the male genital tract by HIV-1 protease inhibitors

21 January 2018

1 reference

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

21 January 2018

1 reference

Plague in Vietnam. Clinical observations and treatment with kanamycin

21 January 2018

1 reference

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

21 January 2018

1 reference

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups

21 January 2018

1 reference

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

21 January 2018

1 reference

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

21 January 2018

1 reference

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

21 January 2018

1 reference

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

21 January 2018

1 reference

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

21 January 2018

1 reference

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

21 January 2018

1 reference

Prevalence and predictive value of intermittent viremia with combination hiv therapy

21 January 2018

1 reference

Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis

21 January 2018

1 reference

Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART

21 January 2018

1 reference

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/338256

1 reference

22 September 2017

1 reference

PubMed ID

11731950